XML 200 R28.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

EQUITY | 12 Months Ended
--- | ---
Dec. 31, 2023
Notes and other explanatory information [abstract] |
EQUITY | NOTE 23 — EQUITY Contributed Capital Equity Issued During the years ended December 31, 2023 and 2022, the Company issued ordinary shares for net cash proceeds of nil and $15,473,334, respectively. During the year ended December 31, 2022, the Company issued the Company ordinary shares with a gross value of $22,581,816 (net $15,202,858) from the IPO proceeds. The Company also raised cash proceed of $270,476 from the share issuance during the IPO. GeniusU Limited issued ordinary shares with a value of $2,655,739 (2021 - $3,308,617) in exchange of cash and conversion from a loan to equity. During the year ended December 31, 2022, Genius Group Limited entered into a Securities Purchase Agreement to issue convertible loan in the principal amount of $18,130,000 in face amount of a senior secured convertible note purchased for $17,000,000. In relation to the offering, the Company has classified the equity portion of the debt note valued at $0 in 2023 ($6,893,064 in 2022) net of debt discount and cost of fund raise. During the year ended December 31, 2022, the Company issued Genius Group Limited ordinary shares with a value of $35,098,001 in exchange for the 5 acquisitions that the company closed. Genius Group Ltd shares were valued using the market approach based on the price per share paid by third parties for Genius Group Ltd shares as of the acquisition date and share delivery date. See below for discussions regarding additional equity issuances. Shares Issued Related to Debt Conversions During the year December 31, 2023, convertible debt obligations consisting of $18,026,388 (2022-$936,543) of principal and accrued interest were converted into Genius Group shares pursuant to conversion offers extended by Genius Group Ltd. See Note 20 — Convertible Debt Obligations for additional information. Stock-Based Compensation During the year ended December 31, 2023 and 2022, the Company granted 873,429 and 560,188 Genius Group share options. The fair value of the options granted in 2023 was $674,704 and 2022 was $2,189,351, with the fair value expensed over the vesting period. During the year ended December 31, 2022, the Company issued 1,511,664 Restricted Stock Units (RSUs) to new hires and are cancelled during 2023 because of termination of the contract. The RSUs fair value of $143,016 is being expensed during 2023 ($350,033 in 2022). The Company values stock options using the Black-Scholes option pricing model and used the following assumptions during the reporting periods: SCHEDULE OF STOCK OPTIONS USING THE BLACK-SCHOLES OPTION PRICING MODEL AND USED THE ASSUMPTIONS
|  | 2023 |  |  | 2022 |
|  | Year ended December 31, |
|  | 2023 |  |  | 2022 |
Risk-free interest rate |  |  | 4.25 | % |  |  | 4.41 | %
Contractual term (years) |  |  | 1-4 |  |  |  | 1-3 |
Expected volatility |  |  | 207.20 | % |  |  | 177.30 | %
Expected dividends |  |  | 0.00 | % |  |  | 0.00 | %
A summary of the option activity during the year ended December 31, 2022 was as follows: SUMMARY OF OPTION ACTIVITY
|  | No of Options |  |  | Weighted Average Share Price |  |  | Weighted Average Remaining Life |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2022 |  |  | 539,760 |  |  | $ | 4.74 |  |  |  | 1 |  |  | $ | 0 |
Granted |  |  | 560,188 |  |  |  | 4.22 |  |  |  | 3 |  |  |  | 0 |
Exercised |  |  | (73.428 | ) |  |  | 5.81 |  |  |  | - |  |  |  | 0 |
Outstanding as of December 31, 2022 |  |  | 1,026,520 |  |  | $ | 4.40 |  |  |  | 2 |  |  | $ | 0 |
A summary of the option activity during the year ended December 31, 2023 was as follows:
|  | No of Options |  |  | Weighted Average Share Price |  |  | Weighted Average Remaining Life |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2023 |  |  | 1,026,520 |  |  | $ | 4.40 |  |  |  | 2 |  |  | $ | 4,517,330 |
Granted |  |  | 873,429 |  |  |  | 0.77 |  |  |  | 4 |  |  |  | 674,704 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 0 |
Expired |  |  | (375,000 | ) |  |  |  |  |  |  |  |  |  |  | (1,320,933 | )
Outstanding as of December 31, 2023 |  |  | 1,524,949 |  |  | $ | 2.54 |  |  |  | 2 |  |  | $ | 3,871,101 |
SCHEDULE OF INFORMATION RELATED TO OPTIONS OUTSTANDING
|  | Options Outstanding |  |  |  |  | Options Exercisable |
Year |  | Exercise Price |  |  | Outstanding Number of Options |  |  | Underlying Common Stock |  | Weighted Average Remaining Life in Years |  |  | Exercisable Number of Warrants |
2019 Share Option |  | $ | 3.56 |  |  |  | 257,478 |  |  | GNS |  |  | 1 |  |  | $ | 257,478 |
2020 Share Option |  |  | 5.81 |  |  |  | 74,640 |  |  | GNS |  |  | 1 |  |  |  | 74,640 |
2021 Share Options |  |  | 5.81 |  |  |  | 134,214 |  |  | GNS |  |  | 3 |  |  |  | 134,214 |
2022 Employee Grants (Options) |  |  | 5.62 |  |  |  | 185,188 |  |  | GNS |  |  | 3 |  |  |  | - |
2023 Employee Grants (Options) |  |  | 0.77 |  |  |  | 873,429 |  |  | GNS |  |  | 4 |  |  |  | 0 |
|  | $ | 2.54 |  |  |  | 1,524,949 |  |  |  |  |  | 2.4 |  |  | $ | 466,332 |
The Company recorded stock-based compensation in the amount of $532,466, $1,308,784 and $293,837 during the years ended December 31, 2023 2022 and 2021 respectively, in connection with the amortization of the grant date value of the stock options. The amount of $863,224 to be recognized as stock-based compensation expense over the period 2024, 2025 and 2026.

X
- Definition The disclosure of issued capital. [Refer: Issued capital] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfIssuedCapitalExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_NotesAndOtherExplanatoryInformationAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration